Cash · 2011–2025
Myriad Genetics cash
$150M+46.1% · FY2025
Myriad Genetics (MYGN) reported $150M in cash for fiscal 2025, +46.1% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $150M | +46.1% | Open → |
| FY20242024-12-31 | $102M | −22.5% | Open → |
| FY20232023-12-31 | $132M | +132.2% | Open → |
| FY20222022-12-31 | $56.9M | −77.9% | Open → |
| FY20212021-12-31 | $257M | +120.0% | Open → |
| FY20202020-12-31 | $117M | +44.1% | Open → |
| FY20192019-12-31 | $81.2M | −10.4% | Open → |
| FY20182018-12-31 | $90.6M | +2.1% | Open → |
| FY20172017-12-31 | $88.7M | −17.9% | Open → |
| FY20162016-12-31 | $108M | −19.8% | Open → |
| FY20152015-12-31 | $135M | +125.6% | Open → |
| FY20142014-12-31 | $59.7M | −16.6% | Open → |
| FY20132013-12-31 | $71.6M | +4.6% | Open → |
| FY20122012-12-31 | $68.4M | −37.1% | Open → |
| FY20112011-12-31 | $109M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +2.3%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Myriad Genetics cash |url=https://companiesranked.com/en/company/myriad-genetics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Myriad Genetics cash. CompaniesRanked. https://companiesranked.com/en/company/myriad-genetics/cash-on-handBibTeX
@misc{companiesranked-en-company-myriad-genetics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Myriad Genetics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/myriad-genetics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000899923-26-000072 · July 31, 2026
{{cite web |title=Myriad Genetics cash — 10-Q (0000899923-26-000072) |url=https://www.sec.gov/Archives/edgar/data/899923/000089992326000072/mygn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-31}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.